What is the dosage of mitotane? How to adjust the dose according to the patient's condition?

Mitotan is a drug mainly used to treat adrenal gland-related cancers such as pheochromocytoma and adrenocortical cancer. Its main function is to slow down the growth of tumors by inhibiting the function of the adrenal cortex. The dosage of mitotane is usually adjusted according to the patient's specific conditions, but generally speaking, the initial dose for adults is usually 250-500 mg 1-3 times a day, and the initial dose will be gradually increased until the desired therapeutic effect and tolerance level are achieved.

During treatment, the dose of mitotane can be adjusted based on patient response and tolerability. If the patient responds well to the initial dose and the side effects are manageable, the doctor may gradually increase the dose. Usually, the patient's maintenance dose is between 2-6 grams per day, and the specific dose needs to be individually adjusted based on the patient's liver function, weight, and disease severity. For those patients who cannot tolerate high doses, doctors will reduce the dose appropriately to ensure continuity of treatment.

Dose adjustment of mitotane requires special attention to the patient's blood concentration of the drug. During the treatment process, doctors will regularly monitor the patient's blood drug concentration to ensure that the drug concentration is within the ideal range to avoid overdose that may lead to serious side effects, such as liver function damage or neurological abnormalities. In addition, the patient's renal function, cardiac function, and other comorbidities are also key factors in dose adjustment. Especially older patients or those with other underlying medical conditions may require lower doses to reduce the risk of side effects.

The efficacy and safety of mitotane require strict monitoring during treatment. Patients need regular blood tests, especially monitoring of liver function, kidney function and adrenal gland function. If serious side effects such as nausea, vomiting, abnormal liver function or neurological symptoms occur, the dose should be adjusted promptly or treatment should be suspended. Patients who use mitotane for a long time also need to have hormone levels tested regularly to ensure the effectiveness of treatment and reduce potential risks.

Reference materials:https://go.drugbank.com/drugs/DB00648